SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

Yee Token ($YEE) is trending with community members highlighting its explosive momentum and resilience, particularly within the Ethereum ecosystem. Bullish sentiment is fueled by increased volume across multiple exchanges, and holders believe $YEE is carving out a strong position as the next big meme token.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending amid speculation surrounding a potential SpaceX IPO and renewed interest in space infrastructure. Community discussions highlight the possibility of sector re-ratings and potential contract awards, while also weighing valuation concerns. Some investors are taking profits while others see long-term potential.

Etsy, Inc. engages in the operation of an online marketplace. It offers handmade products such as shoes, clothing, bags, and accessories. It operates through the following segments: Etsy, Reverb, and Depop. The company was founded in 2005 and is headquartered in New York, NY.

Etsy Inc

Etsy is trending as traders discuss potential holiday season tailwinds and marketplace expansion. Bullish sentiment is fueled by actionable trade alerts and technical analysis pointing to constructive intraday structure. Community members are also weighing factors like the stock's valuation and potential impact from AI initiatives.

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Quincy, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis

Trulieve Cannabis ($TCNNF) is trending amid speculation around potential cannabis rescheduling and its impact on the industry, with community members discussing the possibility of gains and strategic positioning. Some investors believe that rescheduling is near, while others express skepticism due to past disappointments. The potential for federal policy changes and the stock's perceived undervaluation are key talking points.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending as cannabis stocks react to speculation around potential federal policy changes, including the possibility of the Trump administration reclassifying marijuana, which could ease restrictions and provide tax benefits to cannabis companies. Community members are actively discussing potential entry points, trading strategies around options, and the possible impact on specific companies within the sector. Some caution against hype, noting previous false starts, while others express optimism for substantial gains if rescheduling occurs.

Polestar Automotive Holding UK Plc is the Swedish electric performance car brand that engages in the research, development, marketing, commercialization, and sales of battery electric vehicles and related technology solutions. It offers Polestar 2 (PS2), a premium fast-back sedan, the Polestar 3 (PS3), a luxury aero sport-utility vehicle, the Polestar 4 (PS4), a premium sport utility vehicle, the Polestar 5 (PS5), a luxury sport grand-touring sedan, and the Polestar 6 (PS6), a luxury roadster. The company was founded on September 15, 2021 and is headquartered in Gothenburg, Sweden.

Polestar Automotive Holding UK PLC - ADR Class A

Polestar ($PSNY) is trending amid discussions of a potential reverse stock split and overall financial health, with some traders pointing out a possible short squeeze due to limited share availability and upcoming reporting this week. Despite some positive sentiment around sales numbers, the community is also discussing potential red flags on the balance sheet, high cash burn, and concerns about the stock's long-term viability within the competitive EV sector.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi (FRMI) is trending due to scrutiny following its recent IPO and a now-cancelled $150 million funding agreement for its Project Matador data center, sparking community debate about the company's business model and valuation. Discussions revolve around potential tenants, the company's ambitious power delivery schedule, and comparisons to other AI and data center plays. Some traders are capitalizing on the volatility while others express concern about the company's long-term prospects.

The 401jk (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and also the 401k. The 401k total holdings are valued at around $12 trillion USD and it is the most popular retirement savings plan in the US. As time passes forevermore true retirement, or as we like to call it real freedom will only become much harder and harder for people to attain.  Through meme fueled laser focus and cyperphunk ideology the 401jK meme retirement fund token and community aim to point out the absurdities of how rigged our current system is, and how only insiders and those with power are starting the benefit from the increased centralization of cryptocurrency.........while also aiming to flip the $12 trillion USD 401k system to achieve freedom before our backs and knees are breaking.

401jK

401jK is trending as community members rally around its mission to redefine retirement and challenge traditional financial systems. Bullish sentiment is fueled by the project's strong community, new exchange listings, and the belief that it addresses widespread frustration with conventional 401(k) plans. The community is actively promoting the token's vision of financial freedom through memes and content creation.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is trending as the community discusses its volatile price action and potential connection to the broader AI sector following recent market fluctuations. Some traders are pointing to data center growth as a bullish catalyst, while others are wary of overvaluation and potential market manipulation. Discussions also include potential support levels and debate about whether the stock is a long-term hold.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation and rumors surrounding potential marijuana rescheduling, with community members citing reports of a possible executive order from President Trump as soon as Monday. Discussions include the impact of rescheduling on the company, potential price targets, and the possibility of a short squeeze. The community's bullish sentiment is fueled by the potential for eased regulations and increased investment in the cannabis sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Valneva (NASDAQ:VALN) Downgraded by Wall Street Zen to Sell

Wall Street Zen cut shares of Valneva from a "hold" rating to a "sell" rating in a research note on Saturday...

Valneva (NASDAQ:VALN) Stock Price Down 3.1% - What's Next?

Valneva (NASDAQ:VALN) Shares Down 3.1% - Here's What Happened...

Valneva (NASDAQ:VALN) Sees Strong Trading Volume - Here's What Happened

Valneva (NASDAQ:VALN) Sees Strong Trading Volume - What's Next...

Valneva's Lyme Vaccine VLA15 Shows Strong Phase 2 Booster Results With Favorable Safety

(RTTNews) - Valneva SE (VALN) announced positive final immunogenicity and safety data from its Phase 2 study, VLA15-221, evaluating the Lyme disease vaccine candidate VLA15. The study results...

Valneva (NASDAQ:VALN) Releases Earnings Results, Misses Estimates By $0.31 EPS

Valneva (NASDAQ:VALN - Get Free Report) announced its earnings results on Thursday. The company reported ($0.61) earnings per share for the quarter, missing the consensus estimate of ($0.30) by...

Valneva (NASDAQ:VALN) Stock Price Up 3.4% - Time to Buy?

Valneva (NASDAQ:VALN) Stock Price Up 3.4% - Should You Buy...

Valneva (VALN) Projected to Post Earnings on Thursday

Valneva (NASDAQ:VALN) will be releasing its Q3 2025 earnings before the market opens on Thursday, November 20. (View Earnings Report at...

Analysts on Monday expressed divergent opinions on vaccine company Valneva SE (VALN) after the firm said that the United States Food and Drug Administration (FDA) has suspended the license for its Chikungunya vaccine Ixchiq. Shares of Valneva tumbled over 19% on Monday.Jefferies analyst Maury Raycroft lowered the firm's price target on Valneva to $14 from $18 while keeping a ‘Buy’ rating on the shares following the news. The firm, which thinks there is some potential risk for ex-U.S. regulators to change their stance on Ixchiq licensure, added that Ixchiq is "not a major revenue driver" in the near term, according to TheFly.H.C. Wainwright analyst Brandon Folkes, meanwhile, reiterated a ‘Buy’ rating on Valneva. Despite the FDA's decision, Valneva has not revised its revenue guidance for 2025, the analyst noted. The stock selloff on Monday offers an attractive entry for investors who are constructive on a potential positive readout for VLA15, the company’s investigational Lyme disease vaccine, later this year, contends H.C. Wainwright. The firm views the selloff as overdone and keeps an $18 price target on Valneva, TheFly noted.On Stocktwits, retail sentiment around Valneva remained within ‘bullish’ territory over the past 24 hours, while message volume remained at ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:625/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_25_at_12_45_54_PM_png_bbe73f8bfa.webp" alt="VALN's Sentiment Meter and Message Volume as of 12:45 p.m. ET on Aug. 25, 2025 | Source: Stocktwits" width="625" height="61"><figcaption>VALN's Sentiment Meter and Message Volume as of 12:45 p.m. ET on Aug. 25, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user remains hopeful about the company getting acquired.<stembedurl>https://stocktwits.com/Papusa/message/626441643</stembedurl>Another, meanwhile, said that they are cutting their risk.<stembedurl>https://stocktwits.com/nroberts7/message/626439114</stembedurl>Valneva <a target="_blank" rel="noopener noreferrer nofollow" href="https://valneva.com/wp-content/uploads/2025/08/2025_08_25_FDA_IXCHIQ_Update_PR_EN_Final2.pdf">said</a> on Monday that the FDA suspended the license for Ixchiq in the U.S., citing four new reports of serious adverse events consistent with chikungunya-like illness. The suspension, it said, is effective immediately and requires the company to stop shipping and selling Ixchiq in the U.S.All four cases occurred outside the U.S., the company said. While three cases occurred in individuals aged 70 to 82 years, one case occurred in a 55-year-old individual. The company also said that an 82-year-old was hospitalized and discharged after two days.The firm said it believes all cases describe symptoms consistent with those reported during clinical trials, but added that it is continuing to investigate these cases in detail and will pursue further steps about the FDA’s decision if warranted.The company also said that it is evaluating the financial impact of the withdrawal of Ixchiq’s license in the U.S. However, it did not modify its revenue guidance. In the first half of 2025, Ixchiq contributed €7.5 million ($8.74 million) to the company’s €91 million total product sales.VALN stock is up by 116% this year and by about 18% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/tesla-exec-hints-at-possible-price-hike-on-model-y-in-us/chsssVVRdSR">Tesla Executive Hints At Possible Price Hike On Model Y In US: Retail Highlights Negative Catalysts</a>For updates and corrections, email newsroom[at]stocktwits[dot]comExchange Rate: €1= $1.16

An illustrative image of a person holding a medical syringe and a Covid-19 vaccine vial in front of the the Valneva logo displayed on a screen. On Wednesday, January 12, 2021, in Edmonton, Alberta, Canada. (Photo by Artur Widak/NurPhoto via Getty Images)

Valneva Stock Tumbles 19% After FDA Suspension Of Ixchiq License In US, Wall Street Divided On The Impact

While Jefferies lowered its price target on Valneva, H.C. Wainwright kept its $18 price target unchanged. 

Equity

While Jefferies lowered its price target on Valneva, H.C. Wainwright kept its $18 price target unchanged. 



Valneva (VALN) Soars 17.4%: Is Further Upside Left in the Stock?

Valneva (VALN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. It currently provides three proprietary travel vaccines: IXIARO, DUKORAL, and IXCHIQ. The IXIARO is an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis in adults, adolescents, children, and infants aged two months and older. The DUKORAL is a drinkable vaccine that helps prevent diarrhea caused by heat-labile toxin-producing ETEC, as well as cholera. The IXCHIQ is a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also offers additional vaccines, including VLA1553, VLA15, VLA160, VLA200, VLA1601 and others. Valneva was founded on May 28, 2013 and is headquartered in Saint-Herblain, France.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.33	-$0.30	7.07%	BEAT
Q2 '25	-$0.28	-$0.16	41.35%	BEAT
Q1 '25	-$0.28	--	--	N/A
Q4 '24	-$0.19	--	--	N/A
Q3 '24	-$0.27	--	--	N/A

VALN
Valneva SE - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest VALN News

VALNValneva SE - ADR